AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 63 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 6.78 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $73,000 | -8.8% | 21,553 | +9.3% | 0.00% | – |
| Q4 2017 | $80,000 | +471.4% | 19,722 | -14.4% | 0.00% | – |
| Q3 2017 | $14,000 | +16.7% | 23,043 | +0.2% | 0.00% | – |
| Q2 2017 | $12,000 | -36.8% | 22,987 | -6.5% | 0.00% | – |
| Q1 2017 | $19,000 | -17.4% | 24,591 | +0.2% | 0.00% | – |
| Q4 2016 | $23,000 | +27.8% | 24,530 | +0.8% | 0.00% | – |
| Q3 2016 | $18,000 | -14.3% | 24,340 | +50.2% | 0.00% | – |
| Q2 2016 | $21,000 | -36.4% | 16,207 | +9.4% | 0.00% | – |
| Q1 2016 | $33,000 | -70.0% | 14,821 | +1.5% | 0.00% | – |
| Q1 2015 | $110,000 | +124.5% | 14,606 | +2.8% | 0.00% | – |
| Q4 2014 | $49,000 | -75.1% | 14,215 | -39.6% | 0.00% | – |
| Q2 2014 | $197,000 | +26.3% | 23,534 | -4.0% | 0.00% | – |
| Q1 2014 | $156,000 | +19.1% | 24,510 | +33.6% | 0.00% | – |
| Q4 2013 | $131,000 | +1.6% | 18,344 | +7.0% | 0.00% | – |
| Q3 2013 | $129,000 | +31.6% | 17,146 | +1.2% | 0.00% | – |
| Q2 2013 | $98,000 | – | 16,937 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,595,484 | $5,710,000 | 4.85% |
| Cypress Capital Management LLC (WY) | 321,725 | $708,000 | 0.74% |
| Noven Financial Group, Inc. | 103,964 | $229,000 | 0.12% |
| Transform Wealth, LLC | 205,481 | $452,000 | 0.08% |
| Cutter & CO Brokerage, Inc. | 50,000 | $110,000 | 0.04% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 44,500 | $98,000 | 0.04% |
| GHP Investment Advisors, Inc. | 100,000 | $220,000 | 0.03% |
| BRIGHTON JONES LLC | 85,555 | $188,000 | 0.02% |
| Valeo Financial Advisors, LLC | 330,000 | $155,000 | 0.02% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 27,348 | $60,000 | 0.02% |